PROMETHEUS BIOSCIENCES, INC. Net Change in Cash
PROMETHEUS BIOSCIENCES, INC. reported Net Change in Cash of -$179.08 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2023-05-09
- PROMETHEUS BIOSCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$179.08M.
- PROMETHEUS BIOSCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was -$30.22M, a 111.76% decline year-over-year.
- PROMETHEUS BIOSCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-03-31 was $257.03M, a 786.28% increase year-over-year.
- PROMETHEUS BIOSCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2020-03-31 was $29.00M.
- PROMETHEUS BIOSCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was $35.17M, a 82.68% decline from fiscal 2021.
- PROMETHEUS BIOSCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was $203.05M, a 299.67% increase from fiscal 2020.
- PROMETHEUS BIOSCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2020 was $50.80M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2023-03-31 | -$179.08M 10-Q · filed 2023-05-09 | |||
| 2022-12-31 | $35.17M 10-K · filed 2023-02-28 | |||
| 2022-09-30 | -$178.84M 10-Q · filed 2022-11-09 | |||
| 2022-06-30 | -$161.29M 10-Q · filed 2022-08-11 | |||
| 2022-03-31 | -$30.22M 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | $203.05M 10-K · filed 2023-02-28 | |||
| 2021-09-30 | $224.91M 10-Q · filed 2022-11-09 | |||
| 2021-06-30 | $250.19M 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | $257.03M 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | $50.80M 10-K · filed 2023-02-28 | |||
| 2020-09-30 | $9.96M 10-Q · filed 2021-11-12 | |||
| 2020-06-30 | $16.10M 10-Q · filed 2021-08-11 | |||
| 2020-03-31 | $29.00M 10-Q · filed 2021-05-13 |